Related Experiment Video
Updated: May 24, 2026

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Cycloartane triterpenoids from Cassia occidentalis
Shi-Fei Li1, Ying-Tong Di, Rong-Hua Luo
1State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, Yunnan, P. R. China.
Researchers identified new compounds from Cassia occidentalis, with two showing modest anti-HIV-1 activity. This discovery offers potential for developing novel antiviral therapies against HIV-1.
Area of Science:
- Phytochemistry
- Natural Products Chemistry
- Medicinal Chemistry
Background:
- Cassia occidentalis is a plant with a history of traditional medicinal uses.
- Phytochemical studies aim to identify bioactive compounds from medicinal plants.
- HIV-1 remains a significant global health challenge, necessitating new therapeutic strategies.
Purpose of the Study:
- To conduct a phytochemical investigation of Cassia occidentalis.
- To isolate and characterize new and known compounds from the plant.
- To evaluate the anti-HIV-1 activity of the isolated compounds.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation using 1D and 2D Nuclear Magnetic Resonance (NMR) spectroscopy and chemical methods.
- In vitro anti-HIV-1 activity assay to determine EC50 values.
Main Results:
- Two new cycloartane triterpenoids, cycloccidentalic acids A and B, were isolated.
- Five new related saponins, cycloccidentalisides I-V, were identified.
- Sixteen known compounds were also isolated and characterized.
- Compounds 2 and 5 exhibited modest anti-HIV-1 activity with EC50 values of 2.23 µM and 4.36 µM, respectively.
Conclusions:
- The phytochemical analysis of Cassia occidentalis yielded novel cycloartane triterpenoids and saponins.
- The identified compounds, particularly cycloccidentalic acid B and cycloccidentaliside II, demonstrate potential as starting points for anti-HIV-1 drug development.
- Further research is warranted to explore the therapeutic potential of these compounds against HIV-1.
Related Concept Videos
Aromatic Hydrocarbon Cations: Structural Overview
Removing one hydrogen from the intervening CH2 group with both...
Conformations of Cycloalkanes
Cycloalkanes
The IUPAC nomenclature of cycloalkanes follows similar rules that apply to...
Disubstituted Cyclohexanes: cis-trans Isomerism
In cyclohexane, the substituents can occupy different positions generating distinct isomers.
Chair Conformation of Cyclohexane
The hydrogen atoms linked to carbons are arranged in two different axial and equatorial orientations to achieve this staggered...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
